PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引：0
|
作者：
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构：
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源：
Molecular Imaging and Biology | 2019年 / 21卷
关键词：
PET; Affibody; HER2; Cu-64; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [21] Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules
    Rinne, Sara S.
    Leitao, Charles Dahlsson
    Saleh-nihad, Zahra
    Mitran, Bogdan
    Tolmachev, Vladimir
    Stahl, Stefan
    Loefblom, John
    Orlova, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [22] Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging
    Yuping Xu
    Lizhen Wang
    Donghui Pan
    Junjie Yan
    Xinyu Wang
    Runlin Yang
    Mingzhu Li
    Yu Liu
    Min Yang
    EJNMMI Research, 10
  • [23] Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging
    Xu, Yuping
    Wang, Lizhen
    Pan, Donghui
    Yan, Junjie
    Wang, Xinyu
    Yang, Runlin
    Li, Mingzhu
    Liu, Yu
    Yang, Min
    EJNMMI RESEARCH, 2020, 10 (01)
  • [24] Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors
    Adumeau, Pierre
    Raave, Rene
    Boswinkel, Milou
    Heskamp, Sandra
    Wessels, Hans J. C. T.
    van Gool, Alain J.
    Moreau, Mathieu
    Bernhard, Claire
    Da Costa, Laurene
    Goncalves, Victor
    Denat, Franck
    BIOCONJUGATE CHEMISTRY, 2022, 33 (03) : 530 - 540
  • [25] Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
    Miao, Haitao
    Sun, Yuyun
    Jin, Yizi
    Hu, Xichun
    Song, Shaoli
    Zhang, Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Purification and In Vitro Evaluation of an Anti-HER2 Affibody-Monomethyl Auristatin E Conjugate in HER2-Positive Cancer Cells
    Damiani, Isabella
    Castiglioni, Silvia
    Sochaj-Gregorczyk, Alicja
    Bonacina, Fabrizia
    Colombo, Irma
    Rusconi, Valentina
    Otlewski, Jacek
    Corsini, Alberto
    Bellosta, Stefano
    BIOLOGY-BASEL, 2021, 10 (08):
  • [27] In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
    Altai, Mohamed
    Varasteh, Zohreh
    Andersson, Karl
    Eek, Annemarie
    Boerman, Otto
    Orlova, Anna
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (03) : 187 - 195
  • [28] Active Targeting Using HER-2-Affibody-Conjugated Nanoparticles Enabled Sensitive and Specifi c Imaging of Orthotopic HER-2 Positive Ovarian Tumors
    Satpathy, Minati
    Wang, Liya
    Zielinski, Rafal
    Qian, Weiping
    Lipowska, Malgorzata
    Capala, Jacek
    Lee, Gee Young
    Xu, Hong
    Wang, Y. Andrew
    Mao, Hui
    Yang, Lily
    SMALL, 2014, 10 (03) : 544 - 555
  • [29] 64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors
    Pyo, Ayoung
    Yun, Misun
    Kim, Hyeon Sik
    Kim, Tae-Yoon
    Lee, Joong-Jae
    Kim, Jung Young
    Lee, Sunwoo
    Kwon, Seong Young
    Bom, Hee-Seung
    Kim, Hak-Sung
    Kim, Dong-Yeon
    Min, Jung-Joon
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 340 - 346
  • [30] Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
    Baum, Richard P.
    Prasad, Vikas
    Mueller, Dirk
    Schuchardt, Christiane
    Orlova, Anna
    Wennborg, Anders
    Tolmachev, Vladimir
    Feldwisch, Joachim
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) : 892 - 897
12345